Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen

被引：0
|
作者：
Krzakowski, M.
Douillard, J.
Ramlau, R.
Jassem, J.
Szczesna, A.
Zatloukal, P.
von Pawel, J.
Hansen, O.
Sun, X.
机构：
[1] Oncol Ctr Inst M Sklodowska Curie, Warsaw, Poland
[2] Ctr Rene Gauducheau, Nantes, France
[3] Reg Lung Dis Hosp, Poznan, Poland
[4] Med Univ, Gdansk, Poland
[5] Reg Lung Dis Hosp, Otwock, Poland
[6] Charles Univ Prague, Prague, Czech Republic
[7] Asklepios Fachkliniken Munchen, Gauting, Germany
[8] Odense Univ Hosp, Odense, Denmark
[9] Hop Andre Boulloche, Montbeliard, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7511
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase III study of vinflunine versus docetaxel in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) previously treated with a platinum containing regimen
    Ramlau, Rodryg
    Bennouna, Jaafar
    Tan, Eng Huat
    Biesma, Bonne
    Santoro, Armando
    Boni, Corrado
    Klein, Helmut
    Lesniewski, Krzysztof
    Mesia, Ricard
    Gatzemeier, Urlich
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S317 - S318
  • [2] Phase III study of IV vinflunine (VFL) versus IV docetaxel (DTX) in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen
    不详
    EJC SUPPLEMENTS, 2007, 5 (04): : 358 - 358
  • [3] Phase III study of vinflunine (VFL) versus docetaxel (DTX) in advanced/metastatic non-small cell lung cancer (NSCLC) platinum pre-treated patients (PTS)
    Ramlau, Rodryg
    Bennouna, Jaafar
    Tan, Eng Huat
    Biesma, Bonne
    Boni, Corrado
    Welte, Thomas
    Lesniewski, Mark
    Ruiz, German Calderillo
    Gatzemeier, Ulrich
    Mesia, Ricard
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2007, 18 : 24 - 24
  • [4] Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy
    Krzakowski, Maciej
    Ramlau, Rodryg
    Jassem, Jacek
    Szczesna, Aleksandra
    Zatloukal, Petr
    Von Pawel, Joachim
    Sun, Xushan
    Bennouna, Jaafar
    Santoro, Armando
    Biesma, Bonne
    Delgado, Francois M.
    Salhi, Yacine
    Vaissiere, Nathalie
    Hansen, Olfred
    Tan, Eng-Huat
    Quoix, Elisabeth
    Garrido, Pilar
    Douillard, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2167 - 2173
  • [5] The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens
    Fossella, FV
    Rigas, J
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 9 - 12
  • [6] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
    Fossella, FV
    DeVore, R
    Kerr, RN
    Crawford, J
    Natale, RR
    Dunphy, F
    Kalman, L
    Miller, V
    Lee, JS
    Moore, M
    Gandara, D
    Karp, D
    Vokes, E
    Kris, M
    Kim, Y
    Gamza, F
    Hammershaimb, L
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2354 - 2362
  • [7] SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC)
    Borghaei, H.
    Johnson, M. L.
    Garon, E. B.
    He, K.
    Planchard, D.
    Reck, M.
    Popat, S.
    Herbst, R. S.
    Leal, T. A.
    Dumoulin, D.
    De Marinis, F.
    Reynolds, C. H.
    Theelen, W. S. M. E.
    Percent, I.
    Calderon, V. Gutierrez
    Flandin, A. C. Madroszyk
    Shazer, R. L.
    Yan, X.
    Harrigan, R.
    Peters, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1308 - S1308
  • [8] Phase (ph) 2 study of bortezomib ± docetaxel in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC):: Preliminary results.
    Fanucchi, MP
    Belt, RJ
    Fossella, FV
    Natale, RB
    Robert, F
    Fidias, P
    Kelly, K
    Kashala, O
    Shenkein, DP
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 643S - 643S
  • [9] Multicenter, randomized study of Docetaxel versus Docetaxel plus Oblimersen in patients previously treated for non-small cell lung cancer (NSCLC)
    Herbst, Roy S.
    Ansari, Rafat H.
    Gorbunova, V
    Manikhas, G.
    Mansoor, N. Boyd
    Thomas, E.
    Azzoli, Christopher G.
    Robert, Francisco
    Itri, Loretta M.
    Chapman, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S335 - S335
  • [10] Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC).
    Hirata, T
    Kawashita, F
    Ogawa, E
    Masago, K
    Kato, M
    Takada, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
12345